The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease.

ABSTRACT: The focus of this article is to define goals and resulting action plans that can be collectively embraced by interested stakeholders to facilitate new therapeutic approaches to mitigate chronic kidney disease progression. The specific goals include identifying druggable targets, increasing the capacity for preclinical and early clinical development, broadening the availability of new therapeutic approaches, and increasing investment in the development of new therapies to limit chronic kidney disease. Key deliverables include the establishment of new regional, national, and global consortia; development of clinical trial networks; and creation of programs to support the temporary mutual movement of scientists between academia and the biotechnology and pharmaceutical sector. Other deliverabl

SUBMITTER: Pollock C 

PROVIDER: S-EPMC6341008 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature